Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines.
A human monocyte-like cell line, U937, when grown in continuous culture, does not secrete lysosomal enzymes or migrate towards chemotactic factors. When the cells are stimulated by lymphokines, however, they develop the ability both to migrate directionally and to secrete enzymes in response to several types of chemoattractants. The development, by stimulated cells, of chemotactic and secretory responses to one class of chemoattractants, the N- formylated peptides, is accompanied by the appearance on the cells of specific binding sites for these substances. Using tritiated N-formyl- methionyl-leueyl-phenylalanine (fMet-Leu-[(3)H]Phe) as a ligand, it was determined that unstimulated U937 cells possess no detectable binding sites. However, after stimulation with lymphocyte culture supernates for 24, 48, and 72 h, they developed 4,505 (+/-) 1,138, 22,150(+/-) 4,030, and 37,200 (+/-) 8,000 sites/cell, respectively. The dissociation constants for the interaction of fMet-Leu-[SH]Phe with the binding sites were approximately the same regardless of stimulation time and ranged between 15 and 30 nM. The binding of fMet-Leu-[(3)H]Phe by stimulated U937 cells was rapid and readily reversed by the addition of a large excess of unlabeled peptide. The affinity of a series of N-formylated peptides for binding to U937 cells exactly reflected the potency of the peptides in inducing lysosomal enzyme secretion and chemotaxis. The availability of a continuous human monocytic cell line that can be induced to express receptors for N-formylated peptides will provide a useful tool not only for the characterization of such receptors but also for the delineation of regulatory mechanisms involved in cellular differentiation and the chemotactic response.
D001665:Binding Sites; D001667:Binding, Competitive; D002460:Cell Line; D002630:Chemotactic Factors / Q000378:metabolism*; D002634:Chemotaxis, Leukocyte; D005966:Glucuronidase / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008222:Lymphokines / Q000494:pharmacology*; D008247:Lysosomes / Q000201:enzymology; D008715:Methionine / Q000031:analogs & derivatives*; D009000:Monocytes / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D009113:Muramidase / Q000378:metabolism; D009239:N-Formylmethionine / Q000031:analogs & derivatives* / Q000378:metabolism; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009842:Oligopeptides / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism*; D013997:Time Factors; D014316:Tritium
D002630:Chemotactic Factors; D008222:Lymphokines; D009842:Oligopeptides; D011955:Receptors, Drug; D014316:Tritium; D009239:N-Formylmethionine; D009240:N-Formylmethionine Leucyl-Phenylalanine; C024998:N-formylnorleucyl-leucyl-4-phenylalanine; D008715:Methionine; D009113:Muramidase; D005966:Glucuronidase